Search

everythinglearnresearchcommunity

for

Search:↓

DORN1 receptor affects eATP-induced stomatal changes but not eADP in Arabidopsis thaliana.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

Low TRPS1 expression in skin and hair cells is linked to hair problems in Trichorhinophalangeal syndrome.

Clinicians should consider individual factors and communicate risks and benefits when prescribing ritlecitinib for adolescent alopecia areata.

A specific gene mutation causes vitamin D resistance, but certain vitamin D analogs might help.

A new mutation in the KRT86 gene was found to cause the hair disorder monilethrix in a Han family.

Strontium ranelate helps cartilage growth by blocking a specific cell pathway.

Retinoic acid affects male and female muscle energy use and function differently.

FER and TOR signaling help root hair growth in low temperature and low nitrate conditions.

New mutations in the VDR gene cause vitamin D-resistant rickets without hair loss.

GTL1 is needed to control root hair growth and prevent problems when there are too many nutrients.

High levels of auxin increase root hair growth by activating RSL2 and producing ROS, while high phosphate levels hinder growth by repressing RSL2.

A new mutation in the TRPS1 gene was found in a Ukrainian girl with Trichorhinophalangeal syndrome type I.

Ritlecitinib improved hair regrowth and emotional well-being in some alopecia areata patients.

Ritlecitinib is generally safe for adolescents with alopecia areata over 5 years.

Ritlecitinib helps regrow hair in people with alopecia totalis and universalis and is safe to use.

A mutation in the KRTHB5 gene causes hair and nail issues.

RAR-gamma 1 is important for normal skin maintenance and differentiation.

R-spondins and their receptors help increase bone growth and may be used to treat bone loss diseases.

rRSPO1 protein boosts hair growth by activating a key signaling pathway.

KRT14 gene variants cause dermatopathia pigmentosa reticularis, affecting nails, teeth, and hair.

Ritlecitinib effectively regrows and maintains scalp, eyebrow, and eyelash hair in alopecia areata patients.

Thorough history taking is crucial for diagnosing hypothyroidism in rheumatoid arthritis patients.

SMR-2 and SMR-6 are much more toxic than retinoic acid, causing severe symptoms and organ damage in mice.

SMR-2 and SMR-6 are much more toxic than retinoic acid, causing severe side effects.

ROR-alpha may increase the growth of certain breast cancer cells by boosting aromatase, which could affect breast cancer prognosis.

Mutations in the vitamin D receptor cause hereditary vitamin D-resistant rickets, leading to poor bone health and requiring high calcium doses for treatment.

RXR-alpha is strongly expressed in both normal and psoriatic skin and may help in skin cell differentiation and hair growth.

Ritlecitinib 50 mg effectively promotes and sustains hair regrowth in alopecia areata patients.

A child with a rare type of rickets showed some improvement with high doses of vitamin D, but such conditions often respond poorly to treatment.